Alltrna

Earlier this month we took a moment collectively to recharge, so we could return to work with fresh perspectives. From exploring Croatia, Greece, and the UK to catching New England breezes, the Alltrna team found inspiration in every corner of the map. At Alltrna, curiosity…

Raiders of the Lost Codon: Part 2. The treasure hunt for therapeutic #tRNA continues. In this new Advancing RNA article, Alltrna CEO Michelle Werner unpacks what it takes to evolve an ancient molecule into a modern medicine—and why engaging patient communities early is key to…

Last week we participated in the Advancing Research and Care: Propionic Acidemia Conference. From sharing educational resources on genetic testing and Stop Codon Disease to connecting with the propionic acidemia community, we were honored to participate. Thank you to the…

For #PrideMonth2025, Alltrna is reading and discussing The House in the Cerulean Sea by TJ Klune. It’s a beautiful story about identity and belonging. We also gathered for a Pride happy hour to connect and reflect on what inclusion and belonging mean to each of us. #WeAreAlltrna…

Alltrna scientists presented at #RNA25 and the 2025 IRSF #RettSyndrome Scientific Meeting on our advancement of #tRNA as a new therapeutic modality to treat diseases caused by the same underlying mutation. Thanks to our team for their outstanding work! #StopCodonDisease

What does it take to scale breakthrough science into a real-world therapy? For Joyner Eke, a principal engineer on Alltrna’s CMC team, it takes precision, creativity, and a deep commitment to patients. She integrates mass transfer, fluid dynamics, and reaction kinetics to ensure…

At #BIO2025, voices from across the rare disease community came together to share bold ideas, honest reflections, and a vision for a more responsive system. Thank you to the panelists and moderator for an energizing conversation. Below are a few of the key takeaways from the…

Don't forget -- our panel is today at 1:45pm ET in Room 251! #BIO2025

“I thought I had to separate being a CEO and being a rare disease mom. I’ve learned I’m better at both when I embrace both.” In this deeply personal episode of 𝘽𝙚𝙝𝙞𝙣𝙙 𝙩𝙝𝙚 𝘽𝙧𝙚𝙖𝙠𝙩𝙝𝙧𝙤𝙪𝙜𝙝𝙨 podcast, Alltrna CEO Michelle Werner talks with @GrinsteinJ about how…

Congratulations to Sandra Visser, Ph.D., SVP, Head of Therapeutics Development at Alltrna, on being named President of @ASCPT_ClinPharm for 2025-2026! We’re proud to see her leadership recognized by the clinical pharmacology community. #ASCPT2025 #PatientCentricity

When Alltrna CEO Michelle Werner’s son was diagnosed with #Duchenne muscular dystrophy, it was patient advocacy groups that provided not only support, but also vital education to help her understand the disease. As the CEO of a company seeking solutions to some of these diseases,…

In this feature with @BioPharmIntl, our SVP and Head of Therapeutics Development, Sandra Visser, PhD, shares how Alltrna is pioneering a first-in-class platform to engineer tRNAs that read through shared genetic mutations and restore full-length protein production – without…

Patients and families are partnering with regulators and industry to reshape the future of rare disease drug development – driving innovation, advancing clinical progress, and changing what’s possible. At #BIO2025, Michelle Werner joins an inspiring panel of rare disease…

What if one medicine could treat hundreds or thousands of rare genetic diseases? That bold idea is what brought Michelle Werner to Alltrna. In this episode of the Business of Biotech podcast, Michelle shares how her experience as a rare disease parent shaped her decision to lead…

We’ve been walking together throughout May to support the PKU community as part of #MoveYourPheet. It’s been an incredible way to connect as a team while raising awareness for those living with phenylketonuria (PKU), a lifelong rare condition that still lacks targeted treatments.…

With State of the Art and Featured Speakers like Michelle Werner of @Alltrna, Colin Pillai, and Brian Corrigan, #ASCPT2025 is jam packed with exciting scientific content! bit.ly/3Hb77nq

We’ve moved! Alltrna is now in our new labs and offices – a space for bold science and big ideas. Here's to the next chapter in pioneering tRNA therapeutics and building a new future for patients. alltrna.com/life-at-alltrna